FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndromeMadeline Niederkorn, John D. Crispino, Lahiri Konada et al.|Journal of Clinical Investigation|2026Cited by 1
Menin inhibition as a new therapeutic option for the myeloproliferative neoplasmsJohn D. Crispino, Gerard M. McGeehan, Jeremy Q. Wen et al.|Blood|2025Cited by 0